Corsair Gaming Inc vs Davita Inc — how do they compare? Corsair Gaming Inc trades at $13.22 (market cap $1.42B), while Davita Inc trades at $175.04 (market cap $11.29B). The key difference: Davita Inc is far larger — about 8× Corsair Gaming Inc's market cap, and Corsair Gaming Inc is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Corsair Gaming Inc for 25 Days and Davita Inc for 113 Days on average.
| CRSR | DVA | |
|---|---|---|
Market Cap | $1.42B | $11.29B |
Volume | 1,160,938 | 582,204 |
Sector | Technology | Health |
52-Week High | $14.35 | $240.96 |
52-Week Low | $4.58 | $103.87 |
Typical Hold Time | 25 Days | 113 Days |
Enterprise Value | $1.41B | $24.01B |
Signals from Pluang's Aura AI — not financial advice
Corsair Gaming (CRSR) trades at $13.59, down slightly by 0.37% on the day. The stock exhibits a bullish technical signal with recent earnings beats in Q4 2025, Q1 2026, and Q2 2026. Revenue for 2025 was $1.47 billion, though net income was negative $16.16 million. The company launched new products like the VOXARA microphone and acquired Trak Racer assets, signaling growth initiatives. Analyst consensus is a 'Hold' with a price target of $12.40, below the current price, indicating caution despite positive momentum.
The outlook for CRSR is mixed; strong earnings performance and product innovation offer upside, but valuation concerns and negative net income pose risks. Investors should weigh the bullish technical trends and recent institutional interest against the high P/E ratio of 42.23 and analyst price targets suggesting limited near-term gains. Key risks include competitive pressures and execution challenges in the gaming hardware market.
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →